Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Alles Insider Profile
18 Followers
Mark Alles, CEO, CHAIRMAN OF BOARD, Director at Celgene, holds 3.67K shares in Syros Pharmaceuticals (Ticker: SYRS), holds 15.10K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 0.00 shares in Turning Point Therapeutics (Ticker: TPTX).
Mark Alles Celgene (CELG)CEO, CHAIRMAN OF BOARD, Director
Celgene (CELG)
CEO, CHAIRMAN OF BOARD, Director
Ranked #58,074 out of 98,501 Corporate Insiders
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
-3.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Alles holds in companies
Most Profitable Insider Trade
Stock:
Celgene
(CELG)
(CELG)
Rating:Informative Buy
Date:May 17, 2018 - May 17, 2019
Return:+19.30%
The most profitable trade made by Mark Alles
Mark Alles's Trading History
Celgene
Nov 22, 2019
―
Uninformative Buy
―
$24.63M
Syros Pharmaceuticals
Sep 19, 2023
Director
Uninformative Buy
―
$18.73K
Turning Point Therapeutics
Aug 17, 2022
―
Uninformative Sell
152.00K
$0.00
BioMarin Pharmaceutical
May 24, 2023
Director
Uninformative Buy
―
$1.37M
List of latest transactions for each holding click on a transaction to see Mark Alles's performance on stock
You May Also Like
Mark Alles insider profile FAQ
What is the percentage of profitable transactions made by Mark Alles?
The percentage of profitable transactions made by Mark Alles is 29%.
What is the average return per transaction made by Mark Alles?
The average return per transaction made by Mark Alles is -3.70%.
What stocks does Mark Alles hold?
Mark Alles holds: CELG, SYRS, TPTX, BMRN stocks.
What was Mark Alles’s latest transaction?
Mark Alles latest transaction was an Uninformative Buy of ―.
What was Mark Alles's most profitable transaction?
Mark Alles’s most profitable transaction was an Informative Buy of CELG stock on May 17, 2018. The return on the trade was 19.30%.
What is Mark Alles's role in Celgene?
Mark Alles's role in Celgene is CEO, CHAIRMAN OF BOARD, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.